Neighborhood Health and Outcomes in Idiopathic Pulmonary Fibrosis

被引:1
作者
DeDent, Alison M. [1 ]
Collard, Harold R. [1 ]
Thakur, Neeta [1 ]
机构
[1] Univ Calif San Francisco, Div Pulm & Crit Care Med, Dept Med, 513 Parnassus Ave,HSE 1314,Box 0111, San Francisco, CA 94143 USA
关键词
interstitial lung disease; neighborhood health; health disparities; pulmonary fibrosis; SOCIOECONOMIC DISADVANTAGE; DISPARITIES; CARE;
D O I
10.1513/AnnalsATS.202304-323OC
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Rationale: Living in a disadvantaged neighborhood has been associated with worse survival in people with idiopathic pulmonary fibrosis (IPF), however, prior studies have only examined the impact of neighborhood health on outcomes in IPF as a composite measure. Objectives: To investigate the association between neighborhood health and disease severity, measured by pulmonary function at presentation, and death in follow-up, with an additional focus on the contributions of the neighborhood's underlying physical and social factors to these outcomes. Methods: In a retrospective study of participants from the University of California, San Francisco, IPF Cohort (2001-2020), geocoded home addresses were matched to the California Healthy Places Index (HPI), a census-tract measure of neighborhood health. The HPI comprises 25 indicators of neighborhood health that are organized into eight physical and social domains, each of which is weighted and summed to provide a composite HPI score. Regression models were used to examine associations between the HPI as a continuous variable, in quartiles, and across each physical and social domain of the HPI (higher values indicate greater advantage) and forced vital capacity (FVC) percent predicted (% predicted), diffusing capacity of the lung for carbon monoxide (DLCO) % predicted, and death, adjusting for demographic and clinical covariates. We also studied the interaction between disease severity at presentation and neighborhood health in our time-to-event models. Results: In 783 participants with IPF, each 10% increase in HPI was associated with a 1% increase in FVC % predicted and DLCO % predicted (95% confidence intervals [CIs] = 0.55, 1.72; and 0.49, 1.49, respectively). This association appeared primarily driven by the economic, education, access, and social HPI domains. We also observed differences in the associations of HPI with mortality depending on disease severity at presentation. In participants with normal to mildly impaired FVC % predicted (>= 70%) and DLCO % predicted (>= 60%), decreased HPI was associated with higher mortality (hazard ratio = 2.91 Quartile 1 vs. Quartile 4; 95% CI = 1.20, 7.05). No association was observed between the HPI and death for participants with moderate to severely impaired FVC % predicted and DLCO % predicted. Conclusions: Living in disadvantaged neighborhoods was associated with worse pulmonary function in participants with IPF and was independently associated with increased mortality in participants with normal to mild physiological impairment at presentation.
引用
收藏
页码:402 / 410
页数:9
相关论文
共 50 条
  • [21] Idiopathic pulmonary fibrosis
    Hoo, Zhe Hui
    Whyte, Moira K. B.
    THORAX, 2012, 67 (08) : 742 - 746
  • [22] Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis
    Astor, Todd L. L.
    Goldberg, Hilary J. J.
    Snyder, Laurie D. D.
    Courtwright, Andrew
    Hachem, Ramsey
    Pena, Tahuanty
    Zaffiri, Lorenzo
    Criner, Gerard J. J.
    Budev, Marie M. M.
    Thaniyavarn, Tany
    Leonard, Thomas B. B.
    Bender, Shaun
    Barakat, Aliaa
    Breeze, Janis L. L.
    LaCamera, Peter
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2023, 17
  • [23] The burden of idiopathic pulmonary fibrosis: An unmet public health need
    Lee, Augustine S.
    Mira-Avendano, Isabella
    Ryu, Jay H.
    Daniels, Craig E.
    RESPIRATORY MEDICINE, 2014, 108 (07) : 955 - 967
  • [24] Clustering-aided prediction of outcomes in patients with idiopathic pulmonary fibrosis
    Wang, Lijun
    Wu, Peitao
    Liu, Yi
    Patel, Divya C.
    Leonard, Thomas B.
    Zhao, Hongyu
    RESPIRATORY RESEARCH, 2024, 25 (01)
  • [25] Clinical Outcomes of Patients with Combined Idiopathic Pulmonary Fibrosis and Emphysema in the IPF-PRO Registry
    Hyun J. Kim
    Laurie D. Snyder
    Megan L. Neely
    Anne S. Hellkamp
    David L. Hotchkin
    Lake D. Morrison
    Shaun Bender
    Thomas B. Leonard
    Daniel A. Culver
    Lung, 2022, 200 : 21 - 29
  • [26] Longitudinal Changes in Clinical Features, Management, and Outcomes of Idiopathic Pulmonary Fibrosis A Nationwide Cohort Study
    Moon, Sung Woo
    Kim, Song Yee
    Chung, Man Pyo
    Yoo, Hongseok
    Jeong, Sung Hwan
    Kim, Dong Soon
    Song, Jin Woo
    Lee, Hong Lyeol
    Choi, Sun Mi
    Kim, Young Whan
    Kim, Yong Hyun
    Park, Choon-Sik
    Park, Sung-Woo
    Park, Jong Sun
    Jegal, Yangjin
    Lee, Jongmin
    Uh, Soo-Taek
    Kim, Tae-Hyung
    Lee, Jae Ha
    Kim, Yee Hyung
    Shin, Bumsu
    Lee, Hyun-kyung
    Yang, Sei-Hoon
    Lee, Hyun
    Kim, Sang-Heon
    Lee, Eun-Joo
    Choi, Hye Sook
    Shin, Hyejung
    Park, Yong Bum
    Shin, Jong Wook
    Park, Moo Suk
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (05) : 780 - 787
  • [27] Clinical Outcomes of Patients with Combined Idiopathic Pulmonary Fibrosis and Emphysema in the IPF-PRO Registry
    Kim, Hyun J.
    Snyder, Laurie D.
    Neely, Megan L.
    Hellkamp, Anne S.
    Hotchkin, David L.
    Morrison, Lake D.
    Bender, Shaun
    Leonard, Thomas B.
    Culver, Daniel A.
    LUNG, 2022, 200 (01) : 21 - 29
  • [28] Idiopathic Pulmonary Fibrosis in Switzerland: Diagnosis and Treatment
    Funke-Chambour, Manuela
    Azzola, Andrea
    Adler, Dan
    Barazzone-Argiroffo, Constance
    Benden, Christian
    Boehler, Annette
    Bridevaux, Pierre-Olivier
    Brutsche, Martin
    Clarenbach, Christian F.
    Hostettler, Katrin
    Kleiner-Finger, Rebekka
    Nicod, Laurent P.
    Soccal, Paola M.
    Tamm, Michael
    Geiser, Thomas
    Lazor, Romain
    RESPIRATION, 2017, 93 (05) : 363 - 378
  • [29] Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis
    Moss, Benjamin J.
    Ryter, Stefan W.
    Rosas, Ivan O.
    ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2022, 17 : 515 - 546
  • [30] Disparities in Antifibrotic Medication Utilization Among Veterans With Idiopathic Pulmonary Fibrosis
    Kaul, Bhavika
    Lee, Joyce S.
    Petersen, Laura A.
    McCulloch, Charles
    Rosas, Ivan O.
    Bandi, Venkata D.
    Zhang, Ning
    DeDent, Alison M.
    Collard, Harold R.
    Whooley, Mary A.
    CHEST, 2023, 164 (02) : 441 - 449